Community-acquired lower respiratory tract infections - Etiology and treatment

被引:48
作者
Guthrie, R [1 ]
机构
[1] Ohio State Univ, Columbus, OH 43212 USA
关键词
bronchitis; fluoroquinolone; pneumonia;
D O I
10.1378/chest.120.6.2021
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The current therapy for community-acquired lower respiratory tract infections is often empiric, usually involving administration of a beta -lactam or macrolide. However, the increasing prevalence of antibiotic resistance in frequently isolated respiratory tract pathogens has complicated the antimicrobial selection process. This review will discuss the incidence of various respiratory pathogens, as well as update the clinician on the various antimicrobial alternatives available, with particular emphasis on the role of the newer fluoroquinolones in the treatment of acute exacerbations of chronic bronchitis and community-acquired pneumonia.
引用
收藏
页码:2021 / 2034
页数:14
相关论文
共 87 条